SCHEMBL15829166

SCHEMBL15829166

CC(=O)COc1cccc(C#Cc2c(-c3ccccc3)oc3cc(O)c(C(=O)O)cc23)c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN22 Q9Y2R2 20/20 0.78
PTPN11 Q06124 11/20 0.78
PTPN6 P29350 10/20 0.78
PTPRC P08575 10/20 0.70
PTPN9 P43378 10/20 0.70
PTPN2 P17706 9/20 0.70
PTPN1 P18031 9/20 0.70
DUSP3 P51452 9/20 0.70
PTPRG P23470 5/20 0.64
ACP1 P24666 5/20 0.64
PTPN7 P35236 5/20 0.64
PTPN13 Q12923 5/20 0.64
DUSP22 Q9NRW4 3/20 0.64
CDC14A Q9UNH5 3/20 0.64
EPM2A O95278 2/20 0.64
PTPRB P23467 2/20 0.62
PTPN3 P26045 2/20 0.62
PTPRM P28827 2/20 0.62
PTPN12 Q05209 2/20 0.62
DUSP23 Q9BVJ7 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15829172 0.94 PTPN22 (0.74) PTPN22PTPN11PTPN6PTPRCPTPN9
SCHEMBL15829167 0.92 PTPN22 (0.77) PTPN22PTPN11PTPN6PTPRCPTPN9
SCHEMBL15829168 0.92 PTPN22 (0.74) PTPN22PTPN11PTPN6PTPRCPTPN9
SCHEMBL15829159 0.83 PTPN22 (0.83) PTPN22PTPN11PTPN6PTPRCPTPN9
SCHEMBL15829181 0.83 PTPN22 (1.00) PTPN22PTPN11PTPN6PTPRCPTPN9
SCHEMBL15829187 0.83 PTPN22 (1.00) PTPN22PTPN11PTPN6PTPRCPTPN9
SCHEMBL15829188 0.81 PTPN22 (1.00) PTPN22PTPN11PTPN6PTPRCPTPN9
SCHEMBL18231232 0.80 PTPN22 (0.80) PTPN22PTPN11PTPN6PTPRCPTPN9
SCHEMBL13734913 0.78 PTPN22 (1.00) PTPN22PTPN11PTPN6PTPRCPTPN9
SCHEMBL15829190 0.78 PTPN22 (1.00) PTPN22PTPN11PTPN6PTPRCPTPN9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9493436-B2 Tyrosine phosphatase inhibitors and uses thereof to modulate the activity of enzymes involved in the pathology of Mycobacterium tuberculosis INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2016-11-15 US disclosed
US-20140179735-A1 TYROSINE PHOSPHATASE INHIBITORS AND USES THEREOF TO MODULATE THE ACTIVITY OF ENZYMESp INVOLVED IN THE PATHOLOGY OF MYCOBACTERIUM TUBERCULOSIS INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION 2014-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140179735-A1 TYROSINE PHOSPHATASE INHIBITORS AND USES THEREOF TO MODULATE THE ACTIVITY OF ENZYMESp INVOLVED IN THE PATHOLOGY OF MYCOBACTERIUM TUBERCULOSIS PPP3CB, PPP4C, PTPRB PTPN22 69/4885PTPN11 142/4885PTPN6 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.